References
D’Ercole C, Boubli L, Franck J, Casta M, Harle JR, Chagnon C, Cravello L, Leclaire M, Blanc B. Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. Prenatal Diagnosis 1995; 15: 1171¶ 5.
Couvreur J, Desmonts G. Congenital and maternal toxoplasmosis: A review of 300 congenital cases. Dev Med Child Neurol 1962; 4: 519¶ 30.
McCabe RE, Remington JS. Toxoplasma gondii. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and Practice of Infectious Diseases. 2nd ed. New York: JohnWiley & Sons, 1985: 1540¶ 9.
Nicholson DH, Wolchok EB. Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol 1976; 94: 248¶ 54.
Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980; 66: 767¶ 74.
Thalhammer O, Heller-Szöllösy E. Erfabrungen mit routinemäß igem Toxoplasmose-Screening bei Schwangeren zwecks Verhütung angeborener Toxoplasmose. Eine prospektive Untersuchung. Wiener Klin Wochenschrift 1979; 91: 20¶ 5.
Weiss A, Margo CE, Ledford DK, Lockey RF, Brinser JH. Toxoplasmic retinochoroiditis as an initial manifestation of the acquired immune deficiency syndrome. Am J Ophthalmol 1986; 101: 248¶ 9.
Parke DW II, Font RL. Diffuse toxoplasmic retinochoroiditis in a patient with AIDS. Arch Ophthalmol 1986; 104: 571¶ 5.
Desmonts G, Couvreur J. Toxoplasmosis. In: Conn RB (ed) Current Diagnosis. Philadelphia: WB Saunders, 1985: 274¶ 87.
Fischer DH. Ocular toxoplasmosis. In: Tasman WS. Clinical Decisions in Medical Retinal Disease. St. Louis: Mosby, 1994: 289¶ 303.
Thulliez P, Daffos F, Forestier F. Diagnosis of Toxoplasma infection in the pregnant woman and the unborn child: current problems. Scand J Infect Dis 1992; 84(Suppl): 18¶ 22.
St. Georgiev V. Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis. Med Res Rev 1993; 13: 529¶ 68.
Kraubig H. Preventive Behandlung der konnatalen toxoplasmosis. In: Kirchoff H, Kraubig H (eds) Toxoplasmosis. Praktische fragen und ergebniss. Stuttgart: George Thiemes Verlag 1979; 91: 20¶ 5.
Quinlan P, Jabs JA. Ocular toxoplasmosis. In: Ryan SJ, Schachat AP, Murphy RP, Patz A (eds) Retina, vol 2, Medical Retina. St. Louis, Mosby, 1989: 563¶ 74.
Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis 1992; 84(Suppl): 23¶ 31.
Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271¶ 5.
Grossman PL, Remington JS. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979; 28: 445¶ 55.
Briggs GG, Freeman RK, Yaffe SJ, (eds). Drugs in Pregnancy and Lactation: A Brief Guide to Fetal and Neonatal Risk. 3rd ed. Baltimore: Williams & Wilkins, 1990.
O’Connor GR, Frenkel JK. Dangers of steroid treatment in toxoplasmosis: Periocular injections and systemic therapy [editorial]. Arch Ophthalmol 1976; 94: 213.
Ryning FW, McLeod R, Maddox JC, Hunt S, Remington JS. Probable transmission of Toxoplasma gondii by organ transplantation. Ann Int Med 1979; 90: 47¶ 9.
Paque JT, Peyman, GA. Intravitreal clindamycin phosphate in the treatment of vitreous infection. Ophthalmic Surg 1974; 5: 34¶ 9.
Rights and permissions
About this article
Cite this article
Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol 22, 85–88 (1998). https://doi.org/10.1023/A:1006129422690
Issue Date:
DOI: https://doi.org/10.1023/A:1006129422690